Dogwood Therapeutics (DWTX) Deferred Taxes (2024 - 2026)
Dogwood Therapeutics (DWTX) posted quarterly Deferred Taxes of $1193.0 for Q1 2026, down 99.37% year-over-year from $190542.0 in Q1 2025, and down 96.25% quarter-over-quarter from $31841.0 in Q4 2025.
Dogwood Therapeutics (DWTX) Deferred Taxes (2024 - 2026) Analysis & Trends
Dogwood Therapeutics (DWTX) has reported Deferred Taxes for 3 consecutive years, with $1193.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes fell 99.37% year-over-year to $1193.0; the TTM figure through Mar 2026 stood at $31747.0 (down 83.29% YoY), while the FY2025 annual figure was $221096.0, up 44055.47% from the prior year.
- Deferred Taxes retreated to $1193.0 in Q1 2026 per DWTX's latest filing, from $31841.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $190542.0 in Q1 2025 and bottomed at -$1436.0 in Q3 2025.
- Historically, Deferred Taxes has averaged $36964.3 across 3 years, with a median of $671.0 in 2025.
- Annual changes were most pronounced in 2025 — Deferred Taxes surged 6430.22% — and 2026, when it sank 99.37%.
- Dogwood Therapeutics' Deferred Taxes stood at -$503.0 in 2024, then soared by 6430.22% to $31841.0 in 2025, then slumped by 96.25% to $1193.0 in 2026.
- Business Quant data shows DWTX's Deferred Taxes at $1193.0 in Q1 2026, $31841.0 in Q4 2025, and -$1436.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Dogwood Therapeutics | 83.45 Mn | 83.45 Mn | - | -2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,193.00 |
| Dec 31, 2025 | 31,841.00 |
| Sep 30, 2025 | -1,436.00 |
| Jun 30, 2025 | 149.00 |
| Mar 31, 2025 | 190,542.00 |
| Dec 31, 2024 | -503.00 |